Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis

British Journal of Cancer

Volumn 95, Issue 6, 2006, Pages 699-704

  Maggioni, A ^a   Panici, P Benedetti ^b   Dell'Anna, T ^c   Landoni, F ^a   Lissoni, A ^c   Pellegrino, A ^c   Rossi, R S ^c   Chiari, S ^c   Campagnutta, E ^d   Greggi, S ^e   Angioli, R ^f   Manci, N ^b   Calcagno, M ^b   Scambia, G ^g   Fossati, R ^h   Floriani, I ^h   Torri, V ^h   Grassi, R ⁱ   Mangioni, C ^c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

ⁱ TREVIGLIO HOSPITAL   (Italy)

Author keywords

Lymphadenectomy; Ovarian carcinoma; Randomised clinical trial; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADULT; APPENDECTOMY; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OPERATION DURATION; OVARY CANCER; PELVIS CANCER; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROPERITONEAL CANCER; SALPINGOOOPHORECTOMY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748571913     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603323     Document Type: Article

References (21)

1. Baiocchi G, Grosso G, Di Re E, Fontanelli R, Raspagliesi F, Di Re F (1998) Systematic pelvic and paraaortic lymphadenectomy at second look laparotomy for ovarian cancer. Gynecol Oncol 69: 151-156
2. Benedetti Panici P, Greggi S, Maneschi F, Scambia G, Amoroso M, Rabitti C, Mancuso S (1993) Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 51: 150-154
3. Benedetti Panici P, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell'Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C. (2005) Systematic aortic and pelvic lymphadenectomy vs resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomised clinical trial. J Natl Cancer Inst 97: 560-566
4. Burghadt E, Girardi F, Lahousen M, Tamussino K (1991) Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40: 103-106
5. Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, Conte PF (1997) Significance of lymph nodes sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65: 467-472
6. Chen SS, Lee L (1983) Incidence of para-aortic and pelvic lymph-node metastases in epithelial carcinoma of the ovary. Gynecol Oncol 16: 95-100
7. Di Re F, Baiocchi G (2000) Value of lymph node assessment in ovarian cancer: status of the art at the end of second millenium. Int J Gynecol Cancer 10: 435-442
8. Di Re F, Fontanelli R, Raspagliesi F, Di Re E (1989) Pelvic and paraaortic lymphadenectomy in cancer of the ovary. Bailliere's Clin Obstet Gynaecol 13: 131-142
9. FIGO Committee on Gynecologic Oncology (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynaecol Obstet 70: 209-262
10. International Collaborative Ovarian Neoplasm (ICON1) Collaborators (2003) International collaborative Ovarian Neoplasm Trial 1: a randomised trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 95: 125- 132
11. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10-30
12. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
13. Lanza A, D'Addato F, Valli M, Bussone R, Caldarola B, Re A, Olivero F, Ferraris G (1988) Pelvic and para-aortic lymph nodal positivity in the ovarian carcinoma. Its prognostic significance. Eur J Gynaecol Oncol 1: 36-39
14. Liotta LA, Kohn EC, Petricoin EF (2001) Clinical proteomics: personalized molecular medicine. JAMA 286: 2211-2214
15. Musumeci R, Banfi A, Bolis G, Candiani GB, De Palo G, Di Re F, Lucina L, Lattuada A, Mangioni C, Mattioli G, Natale N (1977) Lymphangiography in patients with ovarian epithelial cancer. Cancer 40: 1444-1449
16. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184-197
17. Parmar MKB, Machin D (1995) Survival analysis: a practical approach. Chichester: John Wiley
18. Piver S, Barlow J, Lele S (1978) Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol 52: 100-104
19. Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, Jacobs IJ (2003) Calculation of the risk of ovarian cancer from serial CA - 125 values for preclinical detection in postmenopausal women. J Clin Oncol 21(suppl): 206s-210s
20. Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S; EORTC-ACTION collaborators (2003) European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95: 113-125
21. Tsuruchi N, Kamura T, Tsukamoto N, Akazawa K, Saito T, Kaku T, To N, Nakano H (1993) Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer-a multivariate analysis. Gynecol Oncol 49: 51-55